Goldman Sachs Group Inc. Increases Stake in Waystar Holding Corp. $WAY

Goldman Sachs Group Inc. lifted its stake in Waystar Holding Corp. (NASDAQ:WAY) by 33.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,827,474 shares of the company’s stock after purchasing an additional 705,429 shares during the quarter. Goldman Sachs Group Inc.’s holdings in Waystar were worth $92,600,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of WAY. ANTIPODES PARTNERS Ltd raised its position in shares of Waystar by 120.1% in the 3rd quarter. ANTIPODES PARTNERS Ltd now owns 823 shares of the company’s stock valued at $31,000 after purchasing an additional 449 shares during the last quarter. Danske Bank A S acquired a new position in Waystar in the 4th quarter worth approximately $52,000. EverSource Wealth Advisors LLC increased its holdings in Waystar by 3,219.0% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,394 shares of the company’s stock worth $57,000 after buying an additional 1,352 shares during the period. GAMMA Investing LLC increased its holdings in Waystar by 613.4% in the 4th quarter. GAMMA Investing LLC now owns 1,762 shares of the company’s stock worth $58,000 after buying an additional 1,515 shares during the period. Finally, 1620 Investment Advisors Inc. acquired a new position in Waystar in the 4th quarter worth approximately $77,000.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on WAY shares. TD Cowen reiterated a “buy” rating on shares of Waystar in a report on Wednesday, February 18th. Needham & Company LLC reiterated a “buy” rating and issued a $33.00 price target on shares of Waystar in a report on Thursday, April 30th. Wells Fargo & Company cut their price target on shares of Waystar from $41.00 to $36.00 and set an “overweight” rating on the stock in a report on Thursday, February 19th. Canaccord Genuity Group cut their price target on shares of Waystar from $54.00 to $30.00 and set a “buy” rating on the stock in a report on Wednesday, February 18th. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $41.00 price target on shares of Waystar in a report on Wednesday, February 18th. Three equities research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $35.62.

Waystar Price Performance

Shares of NASDAQ WAY opened at $19.17 on Wednesday. The stock has a market capitalization of $3.68 billion, a price-to-earnings ratio of 28.61, a PEG ratio of 0.75 and a beta of 0.10. Waystar Holding Corp. has a 12 month low of $17.89 and a 12 month high of $41.47. The firm’s 50 day simple moving average is $21.78 and its 200-day simple moving average is $26.50. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.76 and a quick ratio of 1.76.

Waystar (NASDAQ:WAY) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.03. The business had revenue of $313.87 million for the quarter, compared to analysts’ expectations of $311.74 million. Waystar had a net margin of 10.90% and a return on equity of 6.99%. The business’s revenue was up 22.4% on a year-over-year basis. During the same quarter last year, the company earned $0.32 EPS. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. Analysts expect that Waystar Holding Corp. will post 1.46 EPS for the current year.

About Waystar

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.